<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.epi-perspectives.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Epidemiologic Perspectives &amp; Innovations - Most accessed articles</title>
        <link>http://www.epi-perspectives.com</link>
        <description>The most accessed research articles published by Epidemiologic Perspectives &amp; Innovations</description>
        <dc:date>2012-02-01T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.epi-perspectives.com/content/1/1/3" />
                                <rdf:li rdf:resource="http://www.epi-perspectives.com/content/4/1/15" />
                                <rdf:li rdf:resource="http://www.epi-perspectives.com/content/8/1/1" />
                                <rdf:li rdf:resource="http://www.epi-perspectives.com/content/5/1/7" />
                                <rdf:li rdf:resource="http://www.epi-perspectives.com/content/1/1/6" />
                                <rdf:li rdf:resource="http://www.epi-perspectives.com/content/9/1/1" />
                                <rdf:li rdf:resource="http://www.epi-perspectives.com/content/4/1/11" />
                                <rdf:li rdf:resource="http://www.epi-perspectives.com/content/3/1/5" />
                                <rdf:li rdf:resource="http://www.epi-perspectives.com/content/4/1/8" />
                                <rdf:li rdf:resource="http://www.epi-perspectives.com/content/6/1/1" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.epi-perspectives.com/content/1/1/3">
        <title>The missed lessons of Sir Austin Bradford Hill</title>
        <description>Austin Bradford Hill&apos;s landmark 1965 paper contains several important lessons for the current conduct of epidemiology. Unfortunately, it is almost exclusively cited as the source of the &quot;Bradford-Hill criteria&quot; for inferring causation when association is observed, despite Hill&apos;s explicit statement that cause-effect decisions cannot be based on a set of rules. Overlooked are Hill&apos;s important lessons about how to make decisions based on epidemiologic evidence. He advised epidemiologists to avoid over-emphasizing statistical significance testing, given the observation that systematic error is often greater than random error. His compelling and intuitive examples point out the need to consider costs and benefits when making decisions about health-promoting interventions. These lessons, which offer ways to dramatically increase the contribution of health science to decision making, are as needed today as they were when Hill presented them.</description>
        <link>http://www.epi-perspectives.com/content/1/1/3</link>
                <dc:creator>Carl Phillips</dc:creator>
                <dc:creator>Karen Goodman</dc:creator>
                <dc:source>Epidemiologic Perspectives &amp; Innovations 2004, null:3</dc:source>
        <dc:date>2004-10-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1742-5573-1-3</dc:identifier>
                                <prism:require>/content/figures/1742-5573-1-3-toc.gif</prism:require>
                <prism:publicationName>Epidemiologic Perspectives &amp; Innovations</prism:publicationName>
        <prism:issn>1742-5573</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2004-10-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epi-perspectives.com/content/4/1/15">
        <title>Case-cohort design in practice -- experiences from the MORGAM Project</title>
        <description>When carefully planned and analysed, the case-cohort design is a powerful choice for follow-up studies with multiple event types of interest. While the literature is rich with analysis methods for case-cohort data, little is written about the designing of a case-cohort study. Our experiences in designing, coordinating and analysing the MORGAM case-cohort study are potentially useful for other studies with similar characteristics. The motivation for using the case-cohort design in the MORGAM genetic study is discussed and issues relevant to its planning and analysis are studied. We propose solutions for appending the earlier case-cohort selection after an extension of the follow-up period and for achieving maximum overlap between earlier designs and the case-cohort design. Approaches for statistical analysis are studied in a simulation example based on the MORGAM data.</description>
        <link>http://www.epi-perspectives.com/content/4/1/15</link>
                <dc:creator>Sangita Kulathinal</dc:creator>
                <dc:creator>Juha Karvanen</dc:creator>
                <dc:creator>Olli Saarela</dc:creator>
                <dc:creator>Kari Kuulasmaa</dc:creator>
                <dc:creator>for the MORGAM Project</dc:creator>
                <dc:source>Epidemiologic Perspectives &amp; Innovations 2007, null:15</dc:source>
        <dc:date>2007-12-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1742-5573-4-15</dc:identifier>
                                <prism:require>/content/figures/1742-5573-4-15-toc.gif</prism:require>
                <prism:publicationName>Epidemiologic Perspectives &amp; Innovations</prism:publicationName>
        <prism:issn>1742-5573</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2007-12-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epi-perspectives.com/content/8/1/1">
        <title>WINPEPI updated: computer programs for epidemiologists, and their teaching potential</title>
        <description>Background:
The WINPEPI computer programs for epidemiologists are designed for use in practice and research in the health field and as learning or teaching aids. The programs are free, and can be downloaded from the Internet. Numerous additions have been made in recent years.ImplementationThere are now seven WINPEPI programs: DESCRIBE, for use in descriptive epidemiology; COMPARE2, for use in comparisons of two independent groups or samples; PAIRSetc, for use in comparisons of paired and other matched observations; LOGISTIC, for logistic regression analysis; POISSON, for Poisson regression analysis; WHATIS, a &quot;ready reckoner&quot; utility program; and ETCETERA, for miscellaneous other procedures. The programs now contain 122 modules, each of which provides a number, sometimes a large number, of statistical procedures. The programs are accompanied by a Finder that indicates which modules are appropriate for different purposes. The manuals explain the uses, limitations and applicability of the procedures, and furnish formulae and references.
Conclusions:
WINPEPI is a handy resource for a wide variety of statistical routines used by epidemiologists. Because of its ready availability, portability, ease of use, and versatility, WINPEPI has a considerable potential as a learning and teaching aid, both with respect to practical procedures in the planning and analysis of epidemiological studies, and with respect to important epidemiological concepts. It can also be used as an aid in the teaching of general basic statistics.</description>
        <link>http://www.epi-perspectives.com/content/8/1/1</link>
                <dc:creator>Joseph Abramson</dc:creator>
                <dc:source>Epidemiologic Perspectives &amp; Innovations 2011, null:1</dc:source>
        <dc:date>2011-02-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1742-5573-8-1</dc:identifier>
                                <prism:require>/content/figures/1742-5573-8-1-toc.gif</prism:require>
                <prism:publicationName>Epidemiologic Perspectives &amp; Innovations</prism:publicationName>
        <prism:issn>1742-5573</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2011-02-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epi-perspectives.com/content/5/1/7">
        <title>Methods for stratification of person-time and events 
-  a prerequisite for Poisson regression and SIR estimation
</title>
        <description>IntroductionMany epidemiological methods for analysing follow-up studies require the calculation of rates based on accumulating person-time and events, stratified by various factors. Managing this stratification and accumulation is often the most difficult aspect of this type of analysis.TutorialWe provide a tutorial on accumulating person-time and events, stratified by various factors i.e. creating event-time tables. We show how to efficiently generate event-time tables for many different outcomes simultaneously. We also provide a new vocabulary to characterise and differentiate time-varying factors. The tutorial is focused on using a SAS macro to perform most of the common tasks in the creation of event-time tables. All the most common types of time-varying covariates can be generated and categorised by the macro. It can also provide output suitable for other types of survival analysis (e.g. Cox regression). The aim of our methodology is to support the creation of bug-free, readable, efficient, capable and easily modified programs for making event-time tables. We briefly compare analyses based on event-time tables with Cox regression and nested case-control studies for the analysis of follow-up data.
Conclusion:
Anyone working with time-varying covariates, particularly from large detailed person-time data sets, would gain from having these methods in their programming toolkit.</description>
        <link>http://www.epi-perspectives.com/content/5/1/7</link>
                <dc:creator>Klaus Rostgaard</dc:creator>
                <dc:source>Epidemiologic Perspectives &amp; Innovations 2008, null:7</dc:source>
        <dc:date>2008-11-14T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1742-5573-5-7</dc:identifier>
                                <prism:require>/content/figures/1742-5573-5-7-toc.gif</prism:require>
                <prism:publicationName>Epidemiologic Perspectives &amp; Innovations</prism:publicationName>
        <prism:issn>1742-5573</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2008-11-14T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epi-perspectives.com/content/1/1/6">
        <title>WINPEPI (PEPI-for-Windows): computer programs for epidemiologists</title>
        <description>Background:
The WINPEPI (PEPI-for-Windows) computer programs for epidemiologists are designed for use in practice and research in the health field and as learning or teaching aids. They aim to complement other statistics packages. The programs are free, and can be downloaded from the Internet.ImplementationThere are at present four WINPEPI programs: DESCRIBE, for use in descriptive epidemiology, COMPARE2, for use in comparisons of two independent groups or samples, PAIRSetc, for use in comparisons of paired and other matched observations, and WHATIS, a &quot;ready reckoner&quot; utility program. The programs contain 75 modules, each of which provides a number, sometimes a large number, of statistical procedures. The manuals explain the uses, limitations and applicability of specific procedures, and furnish formulae and references.
Conclusions:
WINPEPI provides a wide variety of statistical routines commonly used by epidemiologists, and is a handy resource for many procedures that are not very commonly used or easily found. The programs are in general user-friendly, although some users may be confused by the large numbers of options and results provided. The main limitations are the inability to read data files and the fact that only one of the programs presents graphic results. WINPEPI has a considerable potential as a learning and teaching aid.</description>
        <link>http://www.epi-perspectives.com/content/1/1/6</link>
                <dc:creator>Joseph Abramson</dc:creator>
                <dc:source>Epidemiologic Perspectives &amp; Innovations 2004, null:6</dc:source>
        <dc:date>2004-12-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1742-5573-1-6</dc:identifier>
                                <prism:require>/content/figures/1742-5573-1-6-toc.gif</prism:require>
                <prism:publicationName>Epidemiologic Perspectives &amp; Innovations</prism:publicationName>
        <prism:issn>1742-5573</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2004-12-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epi-perspectives.com/content/9/1/1">
        <title>Social network analysis and agent-based modeling in social epidemiology</title>
        <description>The past five years have seen a growth in the interest in systems approaches in epidemiologic research. These approaches may be particularly appropriate for social epidemiology. Social network analysis and agent-based models (ABMs) are two approaches that have been used in the epidemiologic literature. Social network analysis involves the characterization of social networks to yield inference about how network structures may influence risk exposures among those in the network. ABMs can promote population-level inference from explicitly programmed, micro-level rules in simulated populations over time and space. In this paper, we discuss the implementation of these models in social epidemiologic research, highlighting the strengths and weaknesses of each approach. Network analysis may be ideal for understanding social contagion, as well as the influences of social interaction on population health. However, network analysis requires network data, which may sacrifice generalizability, and causal inference from current network analytic methods is limited. ABMs are uniquely suited for the assessment of health determinants at multiple levels of influence that may couple with social interaction to produce population health. ABMs allow for the exploration of feedback and reciprocity between exposures and outcomes in the etiology of complex diseases. They may also provide the opportunity for counterfactual simulation. However, appropriate implementation of ABMs requires a balance between mechanistic rigor and model parsimony, and the precision of output from complex models is limited. Social network and agent-based approaches are promising in social epidemiology, but continued development of each approach is needed.</description>
        <link>http://www.epi-perspectives.com/content/9/1/1</link>
                <dc:creator>Abdulrahman El-Sayed</dc:creator>
                <dc:creator>Peter Scarborough</dc:creator>
                <dc:creator>Lars Seemann</dc:creator>
                <dc:creator>Sandro Galea</dc:creator>
                <dc:source>Epidemiologic Perspectives &amp; Innovations 2012, null:1</dc:source>
        <dc:date>2012-02-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1742-5573-9-1</dc:identifier>
                                <prism:require>/content/figures/1742-5573-9-1-toc.gif</prism:require>
                <prism:publicationName>Epidemiologic Perspectives &amp; Innovations</prism:publicationName>
        <prism:issn>1742-5573</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2012-02-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epi-perspectives.com/content/4/1/11">
        <title>Defending legitimate epidemiologic research:  combating Lysenko pseudoscience</title>
        <description>This analysis presents a detailed defense of my epidemiologic research in the May 17, 2003 British Medical Journal that found no significant relationship between environmental tobacco smoke (ETS) and tobacco-related mortality. In order to defend the honesty and scientific integrity of my research, I have identified and addressed in a detailed manner several unethical and erroneous attacks on this research. Specifically, I have demonstrated that this research is not &quot;fatally flawed,&quot; that I have not made &quot;inappropriate use&quot; of the underlying database, and that my findings agree with other United States results on this relationship. My research suggests, contrary to popular claims, that there is not a causal relationship between ETS and mortality in the U.S. responsible for 50,000 excess annual deaths, but rather there is a weak and inconsistent relationship. The popular claims tend to damage the credibility of epidemiology.In addition, I address the omission of my research from the 2006 Surgeon General&apos;s Report on Involuntary Smoking and the inclusion of it in a massive U.S. Department of Justice racketeering lawsuit. I refute erroneous statements made by powerful U.S. epidemiologists and activists about me and my research and I defend the funding used to conduct this research. Finally, I compare many aspect of ETS epidemiology in the U.S. with pseudoscience in the Soviet Union during the period of Trofim Denisovich Lysenko. Overall, this paper is intended to defend legitimate research against illegitimate criticism by those who have attempted to suppress and discredit it because it does not support their ideological and political agendas. Hopefully, this defense will help other scientists defend their legitimate research and combat &quot;Lysenko pseudoscience.&quot;</description>
        <link>http://www.epi-perspectives.com/content/4/1/11</link>
                <dc:creator>James Enstrom</dc:creator>
                <dc:source>Epidemiologic Perspectives &amp; Innovations 2007, null:11</dc:source>
        <dc:date>2007-10-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1742-5573-4-11</dc:identifier>
                                <prism:require>/content/figures/1742-5573-4-11-toc.gif</prism:require>
                <prism:publicationName>Epidemiologic Perspectives &amp; Innovations</prism:publicationName>
        <prism:issn>1742-5573</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2007-10-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epi-perspectives.com/content/3/1/5">
        <title>Measuring additive interaction using odds ratios</title>
        <description>Interaction measured on the additive scale has been argued to be better correlated with biologic interaction than when measured on the multiplicative scale. Measures of interaction on the additive scale have been developed using risk ratios. However, in studies that use odds ratios as the sole measure of effect, the calculation of these measures of additive interaction is usually performed by directly substituting odds ratios for risk ratios. Yet assessing additive interaction based on replacing risk ratios by odds ratios in formulas that were derived using the former may be erroneous. In this paper, we evaluate the extent to which three measures of additive interaction &#8211; the interaction contrast ratio (ICR), the attributable proportion due to interaction (AP), and the synergy index (S), estimated using odds ratios versus using risk ratios differ as the incidence of the outcome of interest increases in the source population and/or as the magnitude of interaction increases. Our analysis shows that the difference between the two depends on the measure of interaction used, the type of interaction present, and the baseline incidence of the outcome. Substituting odds ratios for risk ratios, when calculating measures of additive interaction, may result in misleading conclusions. Of the three measures, AP appears to be the most robust to this direct substitution. Formulas that use stratum specific odds and odds ratios to accurately calculate measures of additive interaction are presented.</description>
        <link>http://www.epi-perspectives.com/content/3/1/5</link>
                <dc:creator>Linda Kalilani</dc:creator>
                <dc:creator>Julius Atashili</dc:creator>
                <dc:source>Epidemiologic Perspectives &amp; Innovations 2006, null:5</dc:source>
        <dc:date>2006-04-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1742-5573-3-5</dc:identifier>
                                <prism:require>/content/figures/1742-5573-3-5-toc.gif</prism:require>
                <prism:publicationName>Epidemiologic Perspectives &amp; Innovations</prism:publicationName>
        <prism:issn>1742-5573</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2006-04-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epi-perspectives.com/content/4/1/8">
        <title>Translational methods in biostatistics: linear mixed effect regression models of alcohol consumption and HIV disease progression over time</title>
        <description>Longitudinal studies are helpful in understanding how subtle associations between factors of interest change over time. Our goal is to apply statistical methods which are appropriate for analyzing longitudinal data to a repeated measures epidemiological study as a tutorial in the appropriate use and interpretation of random effects models. To motivate their use, we study the association of alcohol consumption on markers of HIV disease progression in an observational cohort. To make valid inferences, the association among measurements correlated within a subject must be taken into account.We describe a linear mixed effects regression framework that accounts for the clustering of longitudinal data and that can be fit using standard statistical software. We apply the linear mixed effects model to a previously published dataset of HIV infected individuals with a history of alcohol problems who are receiving HAART (n = 197). The researchers were interested in determining the effect of alcohol use on HIV disease progression over time. Fitting a linear mixed effects multiple regression model with a random intercept and random slope for each subject accounts for the association of observations within subjects and yields parameters interpretable as in ordinary multiple regression. A significant interaction between alcohol use and adherence to HAART is found: subjects who use alcohol and are not fully adherent to their HIV medications had higher log RNA (ribonucleic acid) viral load levels than fully adherent non-drinkers, fully adherent alcohol users, and non-drinkers who were not fully adherent.Longitudinal studies are increasingly common in epidemiological research. Software routines that account for correlation between repeated measures using linear mixed effects methods are now generally available and straightforward to utilize. These models allow the relaxation of assumptions needed for approaches such as repeated measures ANOVA, and should be routinely incorporated into the analysis of cohort studies.</description>
        <link>http://www.epi-perspectives.com/content/4/1/8</link>
                <dc:creator>Mariel Finucane</dc:creator>
                <dc:creator>Jeffrey Samet</dc:creator>
                <dc:creator>Nicholas Horton</dc:creator>
                <dc:source>Epidemiologic Perspectives &amp; Innovations 2007, null:8</dc:source>
        <dc:date>2007-09-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1742-5573-4-8</dc:identifier>
                                <prism:require>/content/figures/1742-5573-4-8-toc.gif</prism:require>
                <prism:publicationName>Epidemiologic Perspectives &amp; Innovations</prism:publicationName>
        <prism:issn>1742-5573</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2007-09-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epi-perspectives.com/content/6/1/1">
        <title>Trend tests for the evaluation of exposure-response relationships in epidemiological exposure studies</title>
        <description>One possibility for the statistical evaluation of trends in epidemiological exposure studies is the use of a trend test for data organized in a 2 &#215; k contingency table. Commonly, the exposure data are naturally grouped or continuous exposure data are appropriately categorized. The trend test should be sensitive to any shape of the exposure-response relationship. Commonly, a global trend test only determines whether there is a trend or not. Once a trend is seen it is important to identify the likely shape of the exposure-response relationship. This paper introduces a best contrast approach and an alternative approach based on order-restricted information criteria for the model selection of a particular exposure-response relationship. For the simple change point alternative H1 : &#960;1 = ...= &#960;q &lt;&#960;q+1 = ... = &#960;k an appropriate approach for the identification of a global trend as well as for the most likely shape of that exposure-response relationship is characterized by simulation and demonstrated for real data examples. Power and simultaneous confidence intervals can be estimated as well. If the conditions are fulfilled to transform the exposure-response data into a 2 &#215; k table, a simple approach for identification of a global trend and its elementary shape is available for epidemiologists.</description>
        <link>http://www.epi-perspectives.com/content/6/1/1</link>
                <dc:creator>Ludwig Hothorn</dc:creator>
                <dc:creator>Michael Vaeth</dc:creator>
                <dc:creator>Torsten Hothorn</dc:creator>
                <dc:source>Epidemiologic Perspectives &amp; Innovations 2009, null:1</dc:source>
        <dc:date>2009-03-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1742-5573-6-1</dc:identifier>
                                <prism:require>/content/figures/1742-5573-6-1-toc.gif</prism:require>
                <prism:publicationName>Epidemiologic Perspectives &amp; Innovations</prism:publicationName>
        <prism:issn>1742-5573</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2009-03-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

